Skip to main content

Table 4 Multivariate analysis of recurrence-free survival between patients treated with tamoxifen (TAM) and toremifene (TOR)

From: A comparison of survival outcomes and side effects of toremifene or tamoxifen therapy in premenopausal estrogen and progesterone receptor positive breast cancer patients: a retrospective cohort study

 

HR (95%CI)

P value

Age

0.960(0.903-1.020)

0.191

T

1.602(0.844-3.041)

0.150

Grade

0.817(0.547-1.220)

0.323

N

1.543(0.998-2.385)

0.051

Her-2

0.950(0.856-1.055)

0.336

Local control

0.933(0.521-1.672)

0.816

Chemotherapy

1.249(0.898-1.739)

0.187

TAM-TOR

0.385(0.154-0.961)

0.041

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us